News Immunovia AB

Equities

IMMNOV

SE0006091997

Market Closed - Nasdaq Stockholm Other stock markets 11:29:50 2024-05-10 am EDT			5-day change	1st Jan Change
1.652 ^SEK	-4.73%		-11.28%	-6.77%

Apr. 29	Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024
Apr. 29	Immunovia Streamlines Lab Operations with Move to Research Triangle Park, North Carolina	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024	Apr. 29
Immunovia appoints Dr. Lisa Ford as Clinical Laboratory Director	Apr. 29	AQ
Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina	Apr. 29	AQ
Immunovia Streamlines Lab Operations with Move to Research Triangle Park, North Carolina	Apr. 29	CI
Immunovia Appoints Lisa Ford as Clinical Laboratory Director	Apr. 29	CI
Immunovia publishes the annual report for 2023	Apr. 29	AQ
Immunovia Publishes Interim Report for January-March 2024	Apr. 29	AQ
Immunovia AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Invitation to Immunovia's Q1 presentation	Apr. 23	AQ
Immunovia announces updated financial calendar	Apr. 22	AQ
Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test	Apr. 22	AQ
Immunovia AB Announces Positive Results from the Model-Development Study for Its Next-Generation Pancreatic Cancer Detection Test	Apr. 22	CI
Immunovia, Proteomedix Create Assays for Pancreatic Cancer Detection Test	Apr. 09	MT
Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study	Apr. 09	AQ
Immunovia Successfully Develops Assays to Measure Targeted Proteomedix for Its Next-Generation Pancreatic Cancer Test - Moving Forward Towards Model-Development Study	Apr. 09	CI
Immunovia announces updated financial calendar	Mar. 12	AQ
Transcript : Immunovia AB, 2023 Earnings Call, Feb 21, 2024	Feb. 21
Immunovia Publishes Full Year Report for 2023	Feb. 21	AQ
Immunovia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21	CI
Immunovia AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Immunovia AB

Equities

IMMNOV

SE0006091997

Summary

Filters